Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05973799 · ClinicalTrials.gov registry record · NA

Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes

A NA study of Hypoglycemia and Type1diabetes, sponsored by University of Cincinnati.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT05973799 is a NA study of Hypoglycemia and Type1diabetes that is actively recruiting participants, run by University of Cincinnati. The registered enrollment target is 10 participants, below the 506-participant average among 40 other Hypoglycemia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05973799, a NA study of Hypoglycemia and Type1diabetes, is actively recruiting participants, sponsored by University of Cincinnati.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Iatrogenic hypoglycemia is still considered to be the number one barrier to effective glycemic control in patients with type 1 diabetes (T1D). In a previous study, it was observed in people without diabetes that fasting can be detrimental to the hormonal and hepatic responses to insulin-induced hypoglycemia. In the experiments described herein, the impact fasting has on hypoglycemic counterregulation in people with T1D will be determined.

Interventions

  • OTHER Fasting
  • OTHER Feeding

Study Locations (1)

Ohio

  • University of Cincinnati - Cincinnati

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-10-10
Est. Completion 2024-12-31
Phase NA

Sponsor

University of Cincinnati

245 total trials

What the Registry Record Tells You About NCT05973799

The ClinicalTrials.gov registry entry for NCT05973799 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 506-participant average among 40 other Hypoglycemia trials with a reported enrollment target (98% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypoglycemia appearing as the primary indexed condition, and to 2 interventions - of which Fasting is the first listed.

NCT05973799 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05973799 about?

NCT05973799 is a clinical study titled "Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes". Iatrogenic hypoglycemia is still considered to be the number one barrier to effective glycemic control in patients with type 1 diabetes (T1D). In a previous study, it was observed in people without diabetes that fasting can be detrimental to the hormonal and hepatic responses to insulin-induced hypo...

What is the current status of trial NCT05973799?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2019-10-10. Estimated completion is 2024-12-31.

What conditions does trial NCT05973799 study?

This clinical trial studies the following conditions: Hypoglycemia, Type1diabetes.

What interventions are being tested in trial NCT05973799?

The interventions under investigation include: Fasting (OTHER), Feeding (OTHER).

Who is sponsoring clinical trial NCT05973799?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05973799 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoglycemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.